Copyright
©The Author(s) 2024.
World J Hepatol. Oct 27, 2024; 16(10): 1188-1198
Published online Oct 27, 2024. doi: 10.4254/wjh.v16.i10.1188
Published online Oct 27, 2024. doi: 10.4254/wjh.v16.i10.1188
Figure 1 C2-FH protected against acetaminophen-induced liver injury.
Mice were injected with 300 mg/kg acetaminophen (APAP) intraperitoneally for 24 hours. Thirty minutes after APAP injection, 20 μg/mouse of C2-FH was administered. A: Serum alanine aminotransferase activity, aspartate aminotransferase activity and lactate dehydrogenase levels were examined; B: Liver hematoxylin and eosin staining; C: Quantification of necrotic areas in liver tissues. n = 4/5 per group, magnification, 100 ×, scale bars 100 µm. bP < 0.001 Ctrl vs APAP group. cP < 0.001, dP < 0.0001 APAP vs C2-FH group. Ctrl: Control; APAP: Acetaminophen; ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDH: lactate dehydrogenase.
- Citation: Li CM, Sun T, Yang MJ, Yang Z, Li Q, Shi JL, Zhang C, Jin JF. Complement activation targeted inhibitor C2-FH ameliorates acetaminophen-induced liver injury in mice. World J Hepatol 2024; 16(10): 1188-1198
- URL: https://www.wjgnet.com/1948-5182/full/v16/i10/1188.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i10.1188